Skip to main content

Day: April 29, 2024

CVR Energy Reports First Quarter 2024 Results and Announces a Cash Dividend of 50 Cents

SUGAR LAND, Texas, April 29, 2024 (GLOBE NEWSWIRE) — CVR Energy, Inc. (“CVR Energy” or the “Company”) (NYSE: CVI) today announced net income attributable to CVR Energy stockholders of $82 million, or $0.81 per diluted share, on net sales of $1.9 billion for the first quarter of 2024, compared to net income attributable to CVR Energy stockholders of $195 million, or $1.94 per diluted share, on net sales of $2.3 billion for the first quarter of 2023. Adjusted earnings for the first quarter of 2024 was 4 cents per diluted share compared to adjusted earnings of $1.44 per diluted share in the first quarter of 2023. Net income for the first quarter of 2024 was $90 million, compared to net income of $259 million in the first quarter of 2023. First quarter 2024 EBITDA was $203 million, compared to first quarter 2023 EBITDA of $401 million....

Continue reading

CVR Partners Reports First Quarter 2024 Results and Announces a Cash Distribution of $1.92

SUGAR LAND, Texas, April 29, 2024 (GLOBE NEWSWIRE) — CVR Partners, LP (“CVR Partners” or the “Partnership”) (NYSE: UAN), a manufacturer of ammonia and urea ammonium nitrate (“UAN”) solution fertilizer products, today announced net income of $13 million, or $1.19 per common unit, on net sales of $128 million for the first quarter of 2024, compared to net income of $102 million, or $9.64 per common unit, on net sales of $226 million for the first quarter of 2023. EBITDA was $40 million for the first quarter of 2024 compared to EBITDA of $124 million for the first quarter of 2023. “CVR Partners posted solid operating results for the first quarter of 2024 driven by safe, reliable operations and a combined ammonia production rate of 90 percent, despite a 14-day planned outage at the Coffeyville fertilizer facility,” said Mark Pytosh,...

Continue reading

Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023

•   Preliminary results of NATHALI-01 and updated results of BALLI-01 Phase I clinical studies presented at the American Society of Hematology (ASH) 65th Annual Meeting •   Execution of strategic collaboration and investment agreements with AstraZeneca •   Cécile Chartier, Ph.D., appointed as a director of the Cellectis’ Board of Directors •   Drawdown of the second tranche of €15 million under the credit facility agreement entered into with the European Investment Bank (EIB) •   Cash position of $156 million as of December 31, 20231 NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, today provided business updates and reports preliminary...

Continue reading

Clip Money Inc. Reports 2023 Year End Results

TORONTO, April 29, 2024 (GLOBE NEWSWIRE) — Clip Money, Inc.  (“Clip” or the “Company”) (TSXV:CLIP) (OTCQB:CLPMF), is pleased to announce its financial results for the three months and fiscal year ended December 31, 2023. Clip achieved significant milestones throughout the year, including (i) the expansion of the largest multi-bank deposit network in the United States for businesses, (ii) the strategic investment and partnership with NCR Atleos (NYSE:NATL), (iii) the launch of the Clip Change Order solution and (iv) noteworthy year-over-year customer and revenue growth. Clip’s platform enables cash deposits through the ClipDrop network, which has been deployed across the U.S. and Canada in leading retail locations such as Simon, Brookfield Properties, Spinoso, Tanger, and Bentall Green Oak. In addition to ClipDrop locations, Clip...

Continue reading

Citizens Community Bancorp, Inc. Reports First Quarter 2024 Earnings of $0.39 Per Share; Nonperforming Assets Decreased 31%; Criticized Assets Decreased 25%

EAU CLAIRE, Wis., April 29, 2024 (GLOBE NEWSWIRE) — Citizens Community Bancorp, Inc. (the “Company”) (Nasdaq: CZWI), the parent company of Citizens Community Federal N.A. (the “Bank” or “CCFBank”), today reported earnings of $4.1 million and earnings per diluted share of $0.39 for the first quarter ended March 31, 2024, compared to $3.7 million and $0.35 per diluted share for the fourth quarter ended December 31, 2023, and $3.7 million and $0.35 per diluted share for the first quarter ended March 31, 2023, respectively. The Company’s first quarter 2024 operating results reflected the following changes from the fourth quarter of 2023: (1) an increase in net interest income largely due to interest income of $0.6 million principally from nonaccrual payoffs partially offset by a lower average balance of non-interest bearing commercial...

Continue reading

IES Holdings Announces Fiscal 2024 Second Quarter Results Earnings Release Schedule

HOUSTON, April 29, 2024 (GLOBE NEWSWIRE) — IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) today announced that it will release fiscal 2024 second quarter results before the market opens on Friday, May 3, 2024. About IES Holdings, Inc. IES designs and installs integrated electrical and technology systems and provides infrastructure products and services to a variety of end markets, including data centers, residential housing, and commercial and industrial facilities. Our more than 8,000 employees serve clients in the United States. For more information about IES, please visit www.ies-co.com. Company Contact: Tracy McLauchlinChief Financial OfficerIES Holdings, Inc.(713) 860-1500 Investor Relations Contact: Robert Winters or Stephen PoeAlpha IR Group312-445-2870IESC@alpha-ir.com

Continue reading

Travere Therapeutics to Report First Quarter 2024 Financial Results

SAN DIEGO, Calif., April 29, 2024 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report first quarter 2024 financial results on Monday, May 6, 2024, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET. The webcast and dial-in information can be accessed on the Investor page of Travere’s website at ir.travere.com/events-presentations. Following the live webcast, an archived version of the call will be available for 30 days on the Company’s website. About Travere Therapeutics At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate...

Continue reading

Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

DEER PARK, Ill., April 29, 2024 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc. (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report first quarter 2024 financial results on Thursday, May 9, 2024. Management will host a conference call and live audio webcast to discuss the results at 4:30 p.m. ET (3:30 p.m. CT).Register* (Audio Only)               Click HereIn addition to taking live questions from participants on the conference call, management will be answering emailed questions from investors. Investors can email questions to: investorrelations@etonpharma.com. The live webcast can be accessed on the Investors section of Eton’s website at https://ir.etonpharma.com/. An archived webcast...

Continue reading

iPower Schedules Fiscal Third Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET

RANCHO CUCAMONGA, Calif., April 29, 2024 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and data-driven online retailer and supplier of consumer home, pet and garden products, as well as a provider of value-added ecommerce services, will host a conference call on Tuesday, May 14, 2024 at 4:30 p.m. Eastern time to discuss its financial results for the fiscal third quarter ended March 31, 2024. The Company’s results will be reported in a press release prior to the call. iPower management will host the conference call, followed by a question-and-answer period. Date: Tuesday, May 14, 2024Time: 4:30 p.m. Eastern timeDial-in registration link: hereLive webcast registration link: here Please dial into the conference call 5-10 minutes prior to the start time. If you have any difficulty connecting with...

Continue reading

ARCPOINT TO HOST CONFERENCE CALL TO DISCUSS 2023 Q4 AND FULL YEAR FINANCIAL RESULTS

Greenville, South Carolina, April 29, 2024 (GLOBE NEWSWIRE) — ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) a leading US-based franchise system providing drug testing, alcohol screening, DNA and direct to consumer (“DTC”) clinical lab testing services, announces that it will host a conference call at 4pm Eastern time, Wednesday, May 1, 2024 to review the Company’s 2023 full year and fourth quarter, ending December 31, 2023 results. The dial-in number for the conference call is as follows: Canada / USA Toll Free         1-844-763-8274International Toll +1-647-484-8814 Callers should dial in 5 – 10 min prior to the scheduled start time and ask to join the ARCpoint call: ARCpoint President and CEO, John Constantine commented “We have worked hard to make progress in bringing our costs in line with revenues over the past 14...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.